Loss of Nuclear PTEN Expression Is a Marker of Poor Prognosis in Stage II Colorectal Adenocarcinoma

被引：0
|
作者：
Jang, K-S
Song, Y. S.
Jang, S-H
Min, K-W
Na, W.
Jang, S. M.
Jua, Y. J.
Lee, K. H.
Choi, D.
Paik, S. S.
机构：
[1] Hanyang Univ, Coll Med, Seoul 133791, South Korea
[2] Soon Chun Hyang Univ, Coll Med, Seoul, South Korea
来源：
MODERN PATHOLOGY | 2009年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
600
引用
收藏
页码：134A / 134A
页数：1
相关论文
共 50 条
  • [1] Loss of nuclear PTEN expression is a marker of poor prognosis in stage II colorectal adenocarcinoma
    Jang, S. H.
    Jang, K. S.
    Song, Y. S.
    Lee, K. H.
    Choi, D.
    Paik, S. S.
    [J]. HISTOPATHOLOGY, 2008, 53 : 154 - 154
  • [2] Loss of Nuclear PTEN Expression Is a Marker of Poor Prognosis in Stage II Colorectal Adenocarcinoma
    Jang, K-S
    Song, Y. S.
    Jang, S. H.
    Min, K. W.
    Na, W.
    Jang, S. M.
    Jun, Y. J.
    Lee, K. H.
    Choi, D.
    Paik, S. S.
    [J]. LABORATORY INVESTIGATION, 2009, 89 : 134A - 134A
  • [3] Loss of PTEN Expression Is Associated with Poor Prognosis in Patients with Ampullary Adenocarcinoma
    Shroff, S.
    Overman, M.
    Rashid, A.
    Wang, H.
    Shroff, R.
    Hamilton, S.
    Katz, M. H.
    Lee, J. E.
    Gomez, H. F.
    Abbruzzese, J. L.
    Fleming, J. B.
    Wang, H.
    [J]. LABORATORY INVESTIGATION, 2012, 92 : 448A - 448A
  • [4] Loss of PTEN Expression Is Associated with Poor Prognosis in Patients with Ampullary Adenocarcinoma
    Shroff, S.
    Overman, M.
    Rashid, A.
    Wang, H.
    Shroff, R.
    Hamilton, S.
    Katz, M. H.
    Lee, J. E.
    Gomez, H. F.
    Abbruzzese, J. L.
    Fleming, J. B.
    Wang, H.
    [J]. MODERN PATHOLOGY, 2012, 25 : 448A - 448A
  • [5] Loss of Hes1 expression is associated with poor prognosis in colorectal adenocarcinoma
    Ahadi, Mahsa
    Andrici, Juliana
    Sioson, Loretta
    Sheen, Amy
    Clarkson, Adele
    Gill, Anthony J.
    [J]. HUMAN PATHOLOGY, 2016, 57 : 91 - 97
  • [6] Clinicopathological significance of nuclear PTEN expression in colorectal adenocarcinoma
    Jang, Ki-Seok
    Song, Young Soo
    Jang, Si-Hyong
    Min, Kyueng-Whan
    Na, Woong
    Jang, Se Min
    Jun, Young Jin
    Lee, Kang Hong
    Choi, Dongho
    Paik, Seung Sam
    [J]. HISTOPATHOLOGY, 2010, 56 (02) : 229 - 239
  • [7] Expression of Cortactin Correlates with a Poor Prognosis in Patients with Stages II–III Colorectal Adenocarcinoma
    Jian-hua Cai
    Ren Zhao
    Jian-wei Zhu
    Xiao-long Jin
    Fang-jun Wan
    Kun Liu
    Xiao-pin Ji
    Yan-bo Zhu
    Zheng-gang Zhu
    [J]. Journal of Gastrointestinal Surgery, 2010, 14 : 1248 - 1257
  • [8] AC133 expression associated with poor prognosis in stage II colorectal cancer
    Ying, Xiaofang
    Wu, Jiangxue
    Meng, Xiangqi
    Zuo, Yufang
    Xia, Qing
    Chen, Jinou
    Feng, Yanfen
    Liu, Ranyi
    Li, Liren
    Huang, Wenlin
    [J]. MEDICAL ONCOLOGY, 2013, 30 (01)
  • [9] Expression of CD133 is associated with poor prognosis in stage II colorectal carcinoma
    Park, Youn Young
    An, Chang Hyeok
    Oh, Seong Taek
    Chang, Eun Deock
    Lee, Jaeim
    [J]. MEDICINE, 2019, 98 (32)
  • [10] AC133 expression associated with poor prognosis in stage II colorectal cancer
    Xiaofang Ying
    Jiangxue Wu
    Xiangqi Meng
    Yufang Zuo
    Qing Xia
    Jinou Chen
    Yanfen Feng
    Ranyi Liu
    Liren Li
    Wenlin Huang
    [J]. Medical Oncology, 2013, 30
12345